🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the potential of high doses of rif...
Status
Completed
Location
University of Florida
Start Date
2013-09
Trial ID
NCT01408914
Treatments Being Tested
The purpose of the study is to develop a BCG challenge model for use in sho...
Status
Completed
Location
Fred Hutchinson Cancer Center
Start Date
2022-12-06
Trial ID
NCT05592223
Treatments Being Tested
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
The purpose of the study is to assess the effects of rifampin on the pharma...
Status
Terminated
Location
Ppd Development
Start Date
2010-03
Trial ID
NCT01068756
Treatments Being Tested
The randomized controlled trial is conducted among antiretroviral naive co-...
Status
Completed
Location
Bamrasnaradura Infectious Diseases Institute
Start Date
2007-01
Trial ID
NCT00483054
Treatments Being Tested
Open-label, parallel, 2-arm, fixed-sequence study to investigate the effect...
Status
Completed
Location
QPS Missouri
Start Date
2020-10-24
Trial ID
NCT04606537
Treatments Being Tested
This is a two-part study to be conducted at a single study site in the US. ...
Status
Completed
Location
PPD Development, LP
Start Date
2016-07
Trial ID
NCT02820935
Treatments Being Tested
This study will be a phase I, open label, two arm, fixed sequence crossover...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05
Trial ID
NCT01231542
Treatments Being Tested
RIFAstrat is a Phase 3, double-blind, placebo-controlled, non-inferiority t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07118696
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested